Optimization of Novel 1-Methyl-1H-Pyrazole-5-carboxamides Leads to High Potency Larval Development Inhibitors of the Barber's Pole Worm

被引:31
|
作者
Le, Thuy G. [2 ]
Kundu, Abhijit [3 ]
Ghoshal, Atanu [3 ]
Nguyen, Nghi H. [2 ]
Preston, Sarah [5 ,10 ]
Jiao, Yaqing [5 ]
Ruan, Banfeng [2 ,6 ]
Xue, Lian [1 ]
Huang, Fei [1 ]
Keiser, Jennifer [7 ,8 ]
Hofmann, Andreas [4 ]
Chang, Bill C. H. [5 ]
Garcia-Bustos, Jose [5 ]
Jabbar, Abdul [5 ]
Wells, Timothy N. C. [9 ]
Palmer, Michael J. [9 ]
Gasser, Robin B. [5 ]
Baell, Jonathan B. [1 ,2 ]
机构
[1] Nanjing Tech Univ, Sch Pharmaceut Sci, 30 South Puzhu Rd, Nanjing 211816, Jiangsu, Peoples R China
[2] Monash Univ, Monash Inst Pharmaceut Sci, Med Chem, Parkville, Vic 3052, Australia
[3] TCG Lifesci Private Ltd, Block BN,Plot 7,Salt Lake Elect Complex,Sect 5, Kolkata 700091, W Bengal, India
[4] Griffith Univ, Griffith Inst Drug Discovery, Nathan, Qld 4111, Australia
[5] Univ Melbourne, Fac Vet & Agr Sci, Melbourne Vet Sch, Dept Vet Biosci, Melbourne, Vic 3010, Australia
[6] Hefei Univ Technol, Sch Food & Biol Engn, Hefei 230009, Anhui, Peoples R China
[7] Swiss Trop & Publ Hlth Inst, CH-4051 Basel, Switzerland
[8] Univ Basel, CH-4001 Basel, Switzerland
[9] Med Malaria Venture, CH-1215 Geneva, Switzerland
[10] Federat Univ, Sch Hlth & Life Sci, Ballarat, Vic 3353, Australia
基金
英国医学研究理事会; 澳大利亚研究理事会;
关键词
HAEMONCHUS-CONTORTUS; DERQUANTEL; PREDICTION; MONEPANTEL; RESISTANCE; ABAMECTIN; EFFICACY; MODELS; ASSAY;
D O I
10.1021/acs.jmedchem.8b01544
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A phenotypic screen of a diverse library of small molecules for inhibition of the development of larvae of the parasitic nematode Haemonchus contortus led to the identification of a 1-methyl-1H-pyrazole-5-carboxamide derivative with an IC50 of 0.29 mu M. Medicinal chemistry optimization targeted modifications on the left-hand side (LHS), middle section, and right-hand side (RHS) of the scaffold in order to elucidate the structure-activity relationship (SAR). Strong SAR allowed for the iterative and directed assembly of a focus set of 64 analogues, from which compound 60 was identified as the most potent compound, inhibiting the development of the fourth larval (L4) stage with an IC50 of 0.01 mu M. In contrast, only 18% inhibition of the mammary epithelial cell line MCF10A viability was observed, even at concentrations as high as 50 mu M.
引用
收藏
页码:10875 / 10894
页数:20
相关论文
共 8 条
  • [1] Design and synthesis of benzo[d]oxazol-5-yl)-1-methyl-1H-pyrazole-4-carboxamides as complex II inhibitors
    Xiong, Li
    Zhu, Xiao Lei
    Yang, Guang Fu
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 248
  • [2] Discovery and optimization of novel 3-benzyl-N-phenyl-1H-pyrazole-5-carboxamides as bifunctional antidiabetic agents stimulating both insulin secretion and glucose uptake
    Jo, Jeyun
    Lee, Dahae
    Park, Yeong Hye
    Choi, Hyeonjin
    Han, Jinhee
    Park, Do Hwi
    Choi, You-Kyung
    Kwak, Jinsook
    Yang, Min-Kyu
    Yoo, Jin-Wook
    Moon, Hyung Ryong
    Geum, Dongho
    Kang, Ki Sung
    Yun, Hwayoung
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 217
  • [3] Identification of 5-(1-Methyl-5-(trifluoromethyl)-1H-pyrazol-3-yl)thiophene-2-Carboxamides as Novel and Selective Monoamine Oxidase B Inhibitors Used to Improve Memory and Cognition
    Kaplan, Alan P.
    Keenan, Terence
    Scott, Roderick
    Zhou, Xianbo
    Bourchouladze, Rusiko
    McRiner, Andrew J.
    Wilson, Mark E.
    Romashko, Darlene
    Miller, Regina
    Bletsch, Matthew
    Anderson, Gary
    Stanley, Jennifer
    Zhang, Adia
    Lee, Dong
    Nikpurt, John
    ACS CHEMICAL NEUROSCIENCE, 2017, 8 (12): : 2746 - 2758
  • [4] Synthesis and optimization of novel (3S,5R)-5-(2,2-dimethyl-5-oxo-4-phenylpiperazin-1-yl)piperidine-3-carboxamides as orally active renin inhibitors
    Mori, Yutaka
    Ogawa, Yasuyuki
    Mochizuki, Akiyoshi
    Nakamura, Yuji
    Fujimoto, Teppei
    Sugita, Chie
    Miyazaki, Shojiro
    Tamaki, Kazuhiko
    Nagayama, Takahiro
    Nagai, Yoko
    Inoue, Shin-ichi
    Chiba, Katsuyoshi
    Nishi, Takahide
    BIOORGANIC & MEDICINAL CHEMISTRY, 2013, 21 (18) : 5907 - 5922
  • [5] Identification and optimization of (E)-1-((2-(1-methyl-1H-imidazol-5-yl) quinolin-4-yl) methylene) semithiocarbazones as a novel series of IκB kinase b (IKKb) inhibitors
    Shin, Youngsook
    Cushing, Timothy D.
    Baichwal, Vijay
    Berry, Karen
    Billedeau, Roland
    Bordunov, Viola
    Broka, Chris
    Cardozo, Mario
    Cheng, Peng
    Clark, David
    Dalrymple, Stacie
    DeGraffenreid, Michael
    Gill, Adrian
    Hao, Xiaolin
    Hawley, Ronald C.
    He, Xiao
    Jaen, Juan
    Labadie, Sharada S.
    Labelle, Marc
    Lehel, Csaba
    Lu, Pu-Ping
    McIntosh, Joel
    Miao, Shichang
    Parast, Camran
    Sjogren, Eric
    Smith, Marie-Louise
    Talamas, Francisco X.
    Tonn, George
    Walker, Keith
    Walker, Nigel P. C.
    Wesche, Holger
    Whitehead, Chris
    Wright, Matt
    Browner, Michelle
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 242
  • [6] Structure-aided optimization of 3-O-β-chacotriosyl ursolic acid as novel H5N1 entry inhibitors with high selective index
    Liao, Yixian
    Chen, Lizhu
    Li, Sumei
    Cui, Zi-ning
    Lei, Zhiwei
    Li, Hui
    Liu, Shuwen
    Song, Gaopeng
    BIOORGANIC & MEDICINAL CHEMISTRY, 2019, 27 (18) : 4048 - 4058
  • [7] Discovery and Development of 1-[(2-Bromophenyl)sulfony1]-5methoxy-3-[(4-methyl-1-piperazinyl)methy1]-1H-indole Dimesylate Monohydrate (SUVN-502): A Novel, Potent, Selective and Orally Active Serotonin 6 (5-HT6) Receptor Antagonist for Potential Treatment of Alzheimer's Disease
    Nirogi, Ramakrishna
    Shinde, Anil
    Kambhampati, Rama Sastry
    Mohammed, Abdul Rasheed
    Saraf, Sangram Keshari
    Mohammed, Abdul Rasheed
    Saraf, Sangram Keshari
    Badange, Rajesh Kumar
    Bandyala, Thrinath Reddy
    Bhatta, Venugopalarao
    Bojja, Kumar
    Reballi, Veena
    Subramanian, Ramkumar
    Benade, Vijay
    Palacharla, Raghava Choudary
    Bhyrapuneni, Gopinadh
    Jayarajan, Pradeep
    Goyal, Vinod
    Jasti, Venkat
    JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (05) : 1843 - 1859
  • [8] Optimization of Orally Bioavailable Enhancer of Zeste Homolog 2 (EZH2) Inhibitors Using Ligand and Property-Based Design Strategies: Identification of Development Candidate (R)-5,8-Dichloro-7-(methoxy(oxetan-3-yl)methyl)-2-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3,4-dihydroisoquinolin-1(2H)-one (PF-06821497)
    Kung, Pei-Pei
    Bingham, Patrick
    Brooun, Alexei
    Collins, Michael
    Deng, Ya-Li
    Dinh, Dac
    Fan, Connie
    Gajiwala, Ketan S.
    Grantner, Rita
    Gukasyan, Hovhannes J.
    Hu, Wenyue
    Huang, Buwen
    Kania, Robert
    Kephart, Susan E.
    Krivacic, Cody
    Kumpf, Robert A.
    Khamphavong, Penney
    Kraus, Manfred
    Liu, Wei
    Maegley, Karen A.
    Nguyen, Lisa
    Ren, Shijian
    Richter, Dan
    Rollins, Robert A.
    Sach, Neal
    Sharma, Shikhar
    Sherrill, John
    Spangler, Jillian
    Stewart, Albert E.
    Sutton, Scott
    Uryu, Sean
    Verhelle, Dominique
    Wang, Hui
    Wang, Shuiwang
    Wythes, Martin
    Xin, Shuibo
    Yamazaki, Shinji
    Zhu, Huichun
    Zhu, JinJiang
    Zehnder, Luke
    Edwards, Martin
    JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (03) : 650 - 665